Smartleaf Asset Management
MED icon

Smartleaf Asset Management’s Medifast MED Stock Holding History

Smartleaf Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$279 Buy
+24
New +$274 ﹤0.01% 3450
2024
Q3 		– Sell
-118
Closed -$2.49K – 2954
2024
Q2 		$2.49K Buy
+118
New +$3.14K ﹤0.01% 2138

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Peapod Lane Capital
Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $39.1B AUM 20.96% 1-Year Est. Return
Quinn Opportunity Partners
Quinn Opportunity Partners Charlottesville, Virginia $1.85B AUM 1.27% 1-Year Est. Return

Smartleaf Asset Management's MED Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Medifast (MED) in Q3 2026: 24 shares worth $279. The stake represents ﹤0.01% of the portfolio and ranks #3450 among its holdings. This is a return to the name: Smartleaf Asset Management previously reported a position in MED as recently as Q2 2024.

Smartleaf Asset Management first reported a position in MED in Q2 2024 and has held it in 2 quarters since. The position peaked at $2.49K in Q2 2024. 63 funds tracked by Wall St. Rank hold MED as of Q3 2026.

  • Smartleaf Asset Management held 24 shares of Medifast worth $279 as of Q3 2026.
  • Medifast was a new Smartleaf Asset Management position in Q3 2026.
  • Medifast made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3450 holding.
  • Smartleaf Asset Management first reported a position in Medifast in Q2 2024 and has held it in 2 quarters since.
  • Smartleaf Asset Management's Medifast position peaked at $2.49K in Q2 2024.
  • 63 funds tracked by Wall St. Rank held Medifast as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.